Clinical trial
A Phase I Open Label Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma
NCT00912899 is registered in ClinicalTrials.gov with Cougar Biotechnology, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Open Label Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma
- Lead sponsor
- Cougar Biotechnology, Inc.
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- December 31, 2007
- Completion date
- July 31, 2010
- Enrollment
- 12 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
refractory multiple myeloma